Log In
Print
BCIQ
Print
Print this Print this
 

nadolol (INV102)

  Manage Alerts
Collapse Summary General Information
Company Invion Ltd.
DescriptionAdrenergic receptor beta (ADRB) antagonist
Molecular Target Adrenergic receptor beta (ADRB)
Mechanism of ActionAdrenergic receptor beta (ADRB) antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationAsthma
Indication DetailsTreat mild asthma
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today